Suspected paracetamol overdose in Monrovia, Liberia: a matched case-control study.
Liberia
Liver insufficiency
Paediatrics
Paracetamol
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
30 03 2020
30 03 2020
Historique:
received:
05
04
2019
accepted:
26
02
2020
entrez:
2
4
2020
pubmed:
2
4
2020
medline:
27
2
2021
Statut:
epublish
Résumé
A cluster of cases of unexplained multi-organ failure was reported in children at Bardnesville Junction Hospital (BJH), Monrovia, Liberia. Prior to admission, children's caregivers reported antibiotic, antimalarial, paracetamol, and traditional treatment consumption. Since we could not exclude a toxic aetiology, and paracetamol overdose in particular, we implemented prospective syndromic surveillance to better define the clinical characteristics of these children. To investigate risk factors, we performed a case-control study. The investigation was conducted in BJH between July 2015 and January 2016. In-hospital syndromic surveillance identified children with at least two of the following symptoms: respiratory distress with normal pulse oximetry while breathing ambient air; altered consciousness; hypoglycaemia; jaundice; and hepatomegaly. After refining the case definition to better reflect potential risk factors for hepatic dysfunction, we selected cases identified from syndromic surveillance for a matched case-control study. Cases were matched with in-hospital and community-based controls by age, sex, month of illness/admission, severity (in-hospital), and proximity of residence (community). Between July and December 2015, 77 case-patients were captured by syndromic surveillance; 68 (88%) were under three years old and 35 (46%) died during hospitalisation. Of these 77, 30 children met our case definition and were matched with 53 hospital and 48 community controls. Paracetamol was the most frequently reported medication taken by the cases and both control groups. The odds of caregivers reporting supra-therapeutic paracetamol consumption prior to admission was higher in cases compared to controls (OR 6.6, 95% CI 2.1-21.3). Plasma paracetamol concentration on day of admission was available for 19 cases and exceeded 10 μg/mL in 10/13 samples collected on day one of admission, and 4/9 (44%) collected on day two. In a context with limited diagnostic capacity, this study highlights the possibility of supratherapeutic doses of paracetamol as a factor in multi-organ failure in a cohort of children admitted to BJH. In this setting, a careful history of pre-admission paracetamol consumption may alert clinicians to the possibility of overdose, even when confirmatory laboratory analysis is unavailable. Further studies may help define additional toxicological characteristics in such contexts to improve diagnoses.
Sections du résumé
BACKGROUND
A cluster of cases of unexplained multi-organ failure was reported in children at Bardnesville Junction Hospital (BJH), Monrovia, Liberia. Prior to admission, children's caregivers reported antibiotic, antimalarial, paracetamol, and traditional treatment consumption. Since we could not exclude a toxic aetiology, and paracetamol overdose in particular, we implemented prospective syndromic surveillance to better define the clinical characteristics of these children. To investigate risk factors, we performed a case-control study.
METHODS
The investigation was conducted in BJH between July 2015 and January 2016. In-hospital syndromic surveillance identified children with at least two of the following symptoms: respiratory distress with normal pulse oximetry while breathing ambient air; altered consciousness; hypoglycaemia; jaundice; and hepatomegaly. After refining the case definition to better reflect potential risk factors for hepatic dysfunction, we selected cases identified from syndromic surveillance for a matched case-control study. Cases were matched with in-hospital and community-based controls by age, sex, month of illness/admission, severity (in-hospital), and proximity of residence (community).
RESULTS
Between July and December 2015, 77 case-patients were captured by syndromic surveillance; 68 (88%) were under three years old and 35 (46%) died during hospitalisation. Of these 77, 30 children met our case definition and were matched with 53 hospital and 48 community controls. Paracetamol was the most frequently reported medication taken by the cases and both control groups. The odds of caregivers reporting supra-therapeutic paracetamol consumption prior to admission was higher in cases compared to controls (OR 6.6, 95% CI 2.1-21.3). Plasma paracetamol concentration on day of admission was available for 19 cases and exceeded 10 μg/mL in 10/13 samples collected on day one of admission, and 4/9 (44%) collected on day two.
CONCLUSIONS
In a context with limited diagnostic capacity, this study highlights the possibility of supratherapeutic doses of paracetamol as a factor in multi-organ failure in a cohort of children admitted to BJH. In this setting, a careful history of pre-admission paracetamol consumption may alert clinicians to the possibility of overdose, even when confirmatory laboratory analysis is unavailable. Further studies may help define additional toxicological characteristics in such contexts to improve diagnoses.
Identifiants
pubmed: 32228536
doi: 10.1186/s12887-020-2008-3
pii: 10.1186/s12887-020-2008-3
pmc: PMC7104478
doi:
Substances chimiques
Analgesics, Non-Narcotic
0
Acetaminophen
362O9ITL9D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
139Commentaires et corrections
Type : ErratumIn
Références
PLoS Med. 2018 Feb 20;15(2):e1002508
pubmed: 29462138
N Engl J Med. 1997 Oct 16;337(16):1112-7
pubmed: 9329933
MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1345-7
pubmed: 20010509
J Ethnopharmacol. 2017 Apr 18;202:154-161
pubmed: 28284793
J Gastroenterol Hepatol. 2000 Jan;15(1):9-20
pubmed: 10719741
J Pediatr. 2006 May;148(5):652-658
pubmed: 16737880
Lancet. 2008 Jan 19;371(9608):204
pubmed: 18207015
S Afr Med J. 2013 May;103(5):298-303
pubmed: 23971118
Br J Clin Pharmacol. 2016 Mar;81(3):562-8
pubmed: 26584404
Patient Educ Couns. 2015 Mar;98(3):331-7
pubmed: 25544245
J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):533-535
pubmed: 27846064
Am J Ther. 2014 May-Jun;21(3):174-83
pubmed: 22407198
Liver Int. 2012 Nov;32(10):1543-56
pubmed: 22928722
Acta Paediatr. 2006 Oct;95(10):1165-71
pubmed: 16982484
J Crit Care. 2018 Feb;43:356-360
pubmed: 29132978
Hum Exp Toxicol. 2015 Jan;34(1):12-23
pubmed: 24758786
Scand J Prim Health Care. 2010 Jun;28(2):115-20
pubmed: 20470019
Curr Drug Metab. 2011 Dec;12(10):989-96
pubmed: 21892916
Mayo Clin Proc. 2014 Jan;89(1):95-106
pubmed: 24388027
BMC Pediatr. 2012 Jul 19;12:103
pubmed: 22812400
Bull World Health Organ. 2016 Sep 1;94(9):642-651
pubmed: 27708469
Br J Clin Pharmacol. 2011 Jan;71(1):20-8
pubmed: 21143497
Br J Clin Pharmacol. 2016 Oct;82(4):923-31
pubmed: 27261770
N Engl J Med. 2006 Feb 16;354(7):731-9
pubmed: 16481640
J Clin Transl Hepatol. 2014 Jun;2(2):80-94
pubmed: 26357619
Crit Care. 2015 Feb 23;19:47
pubmed: 25879892